Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count
Journal of Korean Medical Science · 2025
DOI: 10.3346/jkms.2025.40.e28 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Korean Medical Science, 2025. Verfasst von Na Young Ha und 13 weiteren Autor:innen. Beteiligte Einrichtung: Emerging Infectious Diseases Research Institute, Chungnam National University Hospital, Daejeon, Korea. Hauptthemen laut MEDLINE: SARS-CoV-2, Antibodies, Neutralizing, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea National Institute of Health, National Research Foundation of Korea.
Abstract (Originalsprache)
BACKGROUND: We evaluated severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-specific humoral and cellular responses for up to 6 months after the 3rd dose of ancestral coronavirus disease 2019 (COVID-19) vaccination in people living with HIV (PLWH) and healthy controls (HCs) who were not infected with COVID-19. METHODS: Anti-spike receptor-binding domain IgG (anti-RBD IgG) concentrations using chemiluminescence immunoassay and neutralizing antibodies using focus reduction neutralization test (FRNT) were assessed at 1 week after each dose of vaccination, and 3 and 6 months after the 3rd dose in 62 PLWH and 25 HCs. T-cell responses using intracellular cytokine stain were evaluated at 1 week before, and 1 week and 6 months after the 3rd dose. RESULTS: At 1 week after the 3rd dose, adequate anti-RBD IgG (> 300 binding antibody unit /mL) was elicited in all PLWH except for one patient with 36 CD4 T-cell count/mm³. The geometric mean titers of 50% FRNT against wild type (WT) and omicron BA.5 strains of SARS-CoV-2 in PLWH with CD4 T-cell count ≥ 500 cells/mm³ (high CD4 recovery, HCDR) were comparable to HC, but they were significantly decreased in PLWH with CD4 T-cell count < 500/mm³ (low CD4 recovery, LCDR). After adjusting for age, gender, viral suppression, and number of preexisting comorbidities, CD4 T-cell counts < 500/mm³ significantly predicted a poor magnitude of neutralizing antibodies against WT, omicron BA.5, and XBB 1.5 strains among PLWH. Multivariable linear regression adjusting for age and gender revealed that LCDR was associated with reduced neutralizing activity (P = 0.017) and interferon-γ-producing T-cell responses (P = 0.049 for CD T-cell; P = 0.014 for CD8 T-cell) against WT, and strongly associated with more decreased cross-neutralization against omicron BA.5 strains (P < 0.001). CONCLUSION: HCDR demonstrated robust humoral and cell-mediated immune responses after a booster dose of ancestral SARS-CoV-2 vaccine, whereas LCDR showed diminished immune responses against WT virus and more impaired cross-neutralization against omicron BA.5 strain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emerging Infectious Diseases Research Institute, Chungnam National University Hospital, Daejeon, Korea.
- Translational Immunology Institute, Chungnam National University, Daejeon, Korea.
- Division of Clinical Research for Vaccine, Center for Vaccine Research, Korea National Institute of Infectious Diseases, Cheongju, Korea.
- Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.
- Department of Health Care Policy Research, Korea Institute for Health and Social Affairs, Sejong, Korea.
- Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea. idalicekim@gmail.com.
ORCID-Profile: Na Young Ha, Ah-Ra Kim, Hyeongseok Jeong, Shinhye Cheon, Cho Rong Park, Jin Ho Choe, Hyo Jung Kim, Jae Won Yoon, Miryoung Kim, Mi Yeong An, Sukyoung Jung, Hyeon Nam Do, Junewoo Lee, Yeon-Sook Kim
Förderung
- Korea National Institute of Health
- National Research Foundation of Korea
Zitieren
APA
Ha, N. Y., Kim, A. R., Jeong, H., Cheon, S., Park, C. R., Choe, J. H., Kim, H. J., Yoon, J. W., Kim, M., An, M. Y., Jung, S., Do, H. N., Lee, J., & Kim, Y. S. (2025). Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2025.40.e28
Vancouver
Ha NY, Kim AR, Jeong H, Cheon S, Park CR, Choe JH, et al. Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count. Journal of Korean Medical Science. 2025. doi:10.3346/jkms.2025.40.e28
BibTeX
@article{Ha2025,
author = {Ha, Na Young and Kim, Ah-Ra and Jeong, Hyeongseok and Cheon, Shinhye and Park, Cho Rong and Choe, Jin Ho and Kim, Hyo Jung and Yoon, Jae Won and Kim, Miryoung and An, Mi Yeong and Jung, Sukyoung and Do, Hyeon Nam and Lee, Junewoo and Kim, Yeon-Sook},
title = {Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count},
journal = {Journal of Korean Medical Science},
year = {2025},
doi = {10.3346/jkms.2025.40.e28}
}
EUVIMED